Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2

PURPOSE: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity and its ability to induce apoptosis in cancer cells while sparing most normal cells. We evaluated whether docetaxel enhances TRAIL-mediated apoptosis in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Won Hyeok, Kim, Seong Cheol, Kim, Song Hee, Yoon, Ji Hyung, Moon, Kyung Hyun, Cheon, Sang Hyeon, Kwon, Taekmin, Kim, Young Min, Park, Jeong Woo, Lee, Sang Hun, Lee, Jeong Min, Park, Sungchan, Chung, Benjamin I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307646/
https://www.ncbi.nlm.nih.gov/pubmed/36593705
http://dx.doi.org/10.5534/wjmh.220073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307646/
https://www.ncbi.nlm.nih.gov/pubmed/36593705
http://dx.doi.org/10.5534/wjmh.220073

Ejemplares similares